dupilumab
sanofi,regeneron pharmaceuticals
['dupixent', 'dupilumab']
new dupixent (dupilumab) data at eadv 2022 adds to body of evidence across multiple inflammatory skin diseases 
THE PHARMA DATA is an Information-Centric Website focused mainly on latest Pharma News, Press Release, Industry related updates, Events and Conferences.